Document is current
Any future updates will be listed below
-
Authors
Montero-Vilchez, Trinidad
Gálvez-Martín, Patricia https://orcid.org/0000-0001-9724-8560
Sanabria-de la Torre, Raquel
Cuenca-Barrales, Carlos
Molina-Leyva, Alejandro
Martinez-Puig, Daniel
Velasco-Alvarez, Javier
Arias-Santiago, Salvador
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05813054 at ClinicalTrials.govDocuments that mention this clinical trial
Oral Supplementation with a New Hyaluronic Acid Matrix Ingredient Improves Skin Brightness, Hydration, Smoothness, and Roughness: Results from a Randomized, Double-Blinded, Placebo-Controlled Study
https://doi.org/10.1007/s13555-025-01447-6
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 16 May 2025
First Online: 11 June 2025
Declarations
:
: The present work was funded by Bioiberica. Patricia Gálvez-Martín, Daniel Martinez-Puig and Javier Velasco-Alvarez are full-time employees of Bioiberica. Trinidad Montero-Vilchez, Raquel Sanabria-de la Torre, Carlos Cuenca-Barrales, Alejandro Molina-Leyva and Salvador Arias-Santiago have nothing to disclose.
: The study was carried out at the Dermatology Department of Hospital Universitario Virgen de las Nieves de Granada in accordance with international standards of Good Clinical Practice and the Declaration of Helsinki and was approved by the Granada Ethics Committee on 30 June 2022 (code 0748-N-22). The study population was healthy women (entirely voluntary) who met all the inclusion criteria and none of the exclusion criteria. Participants provided written informed consent before study-related procedures.
